Effects of garlic on atherosclerosis

Nutrition

Volumn 13, Issue 7-8, 1997, Pages 656-663

  Orekhov, Alexander N ^a,d   Grünwald, Jörg ^b,c  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b Lichtwer Pharma GmbH   (Germany)

^c PhytoPharm Consulting GmbH   (Germany)

^d INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Atherosclerosis; Cardiovascular diseases; Clinical trials; Garlic; Prevention; Risk factors; Treatment

Indexed keywords

CHOLESTEROL; GARLIC EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL PROLIFERATION; CHOLESTEROL INTAKE; DISEASE CONTROL; GARLIC; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID STORAGE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT PLANNING;

ALLIUM SATIVUM; ANIMALIA; THROMBUS;

EID: 17044441247     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(97)83010-9     Document Type: Article

References (77)

1. Fabris F, Zanocchi M, Bo M, Fonte G, Fianra U, Poli L. Risk factors for atherosclerosis and aging. Int Angiol 1994;13:52
2. Matts JP, Buchwald H, Fitch LL, et al. Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overal mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction. J Clin Epidemiol 1995;48:389
3. Naito M, Hayashi T, Iguchi A. New approaches to the prevention of atherosclerosis. Drugs 1995;50:440
4. Neil A, Silagy C. Garlic: its cardio-protective properties. Curr Opin Lipidol 1994;5:6
5. Silagy C, Neil A. Garlic as a lipid lowering agent - a meta-analysis. J R Coll Physicians Lond 1994;28:39
6. Silagy C, Neil A. A meta-analysis of the effect of garlic on blood pressure. J Hyperten 1994;12:463
7. Bordia A, Bansal HC, Arora SK, Singh SV. Effect of the essential oils of garlic and onion on alimentary hyperlipemia. Atherosclerosis 1975;21:15
8. Bordia A, Arora SK, Kothari LK, et al. The protective action of essential oils of onion and garlic in cholesterol-fed rabbits. Atherosclerosis 1975;22:103
9. Jain RC. Onion and garlic in experimental cholesterol atherosclerosis in rabbits, Part 1. Effect on serum lipids and development of atherosclerosis. Artery 1975;1:115
10. Kritchevsky D. Effect of garlic on experimental atherosclerosis in rabbit. Artery 1975;1:319
11. Jain RC. Onion and garlic in experimental cholesterol induced atherosclerosis. Indian J Med Res 1976;64:1509
12. Bordia A, Verma SK, Khabia BL, et al. The effective of active principle of garlic and onion on blood lipids and experimental atherosclerosis in rabbits and their comparison with clofibrate. J Assoc Physicians India 1977;25:509
13. Jain RC, Konar DB. Effect of garlic oil in experimental cholesterol atherosclerosis. Atherosclerosis 1978;29:125
14. Bordia AK, Verma SK. Garlic on the reversibility of experimental atherosclerosis. Indian Heart J 1978;30:47
15. Sainani GS, Desai DB, Natu MN, Katrodia KM, Valame VP, Sainani PG. Onion, garlic, and experimental atherosclerosis. Jpn Heart J 1979;20:351
16. Bordia A, Verma SK. Effect of garlic feeding on regression of experimental atherosclerosis in rabbits. Artery 1980;7:428
17. Mirhadi SA, Singh S, Gupta PP. Effect of garlic supplementation to cholesterol-rich diet on development of atherosclerosis in rabbits. Indian J Exp Biol 1991;29:162
18. Lata S, Saxena KK, Bhasin V, Saxena RS, Kumar A, Srivastava VK. Beneficial effects of Allium sativum, Allium cepa and Commiphora mukul on experimental hyperlipidemia and atherosclerosis - a comparative evaluation. J Postgrad Med 1991;37:132
19. Heinle H, Betz E. Effects of dietary garlic supplementation in a rat model of atherosclerosis. Arzneimittelforschung 1994;44:614
20. Gebhardt R. Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids 1993;28:613
21. Sendl A, Schliack M, Loser R, Stanislaus F, Wagner H. Inhibition of cholesterol synthesis in vitro by extracts and isolated compounds prepared from garlic and wild garlic. Atherosclerosis 1992;94:79
22. Gebhardt R. Amplification of palmitate-induced inhibition of cholesterol biosynthesis in cultured rat hepatocytes by garlic-derived organosulfur compounds. Phytomedicine 1995;2:29
23. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 1993;119:599
24. Kannel WB, Neaton JD, Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT: Multiple Risk Factor Interventional Trial. Am Heart J 1986;112:825
25. Martin N, Bardisa L, Pantoja C, Roman R, Vargas M. Experimental cardiovascular depressant effects of garlic (Allium sativum) dialysate. J Ethnopharmacol 1992;37:145
26. Mayeux PR, Agrawal KC, Tou JS, et al. The pharmacological effects of allicin, a constituent of garlic oil. Agents Actions 1988;25:182
27. Foushee DB, Ruffin J, Banerjee U. Garlic as a natural agent for the treatment of hypertension: a preliminary report. Cytobios 1982;34:145
28. Aqel MB, Gharaibah MN, Salhab AS. Direct relaxant effects of garlic juice on smooth and cardiac muscles. J Ethnopharmacol 1991;33:13
29. Siegel G, Walter A, Schnalke F, et al. Potassium channel activation, hyperpolarization, and vascular relaxation. Z Kardiol 1991;80:9
30. Siegel G. Changes in vascular tone and calcium metabolism. Z Phytother 1995;Abstract:14
31. Winocour PD. Platelets, vascular disease, and diabetes mellitus. Can J Physiol Pharmacol 1994;72:295
32. Sobenin IA, Tertov VV, Orekhov AN, Smirnov VN. Synergetic effect of desialylated and glycated low density lipoproteins on cholesterol accumulation in cultured smooth muscle intimal cells. Atherosclerosis 1991;89:151
33. Sobenin IA, Tertov VV, Orekhov AN. Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients. Int Angiol 1994;13:78
34. Jain RC, Vyas CR, Mahatma OP. Letter: Hypoglycaemic action of onion and garlic. Lancet 1973;2:1491
35. Zacharias NT, Sebastian KL, Philip B, Augusti KT. Hypoglycemic and hypolipidaemic effects of garlic in sucrose fed rabbits. Indian J Physiol Pharmacol 1980;24:151
36. Sheela CG, Augusti KT. Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian J Exp Biol 1992;30:523
37. Swanston Flatt SK, Day C, Bailey CJ, Flatt PR. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia 1990;33:462
38. Kiesewetter H, Jung F, Pindur G, Jung EM, Mrowietz C, Wenzel E. Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int J Clin Pharmacol Ther Toxicol 1991;29:151
39. Mansell P, Leatherdale B, Lloyd J, Reckless JPD. Garlic, serum lipids and cardiovascular risk factors in diabetes. Z Phytother 1995; Abstract:16
40. Bakhsh R, Chughtai MI. Influence of garlic on serum cholesterol, serum triglycerides, serum total lipids and serum glucose in human subjects. Nahrung 1984;28:159
41. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801
42. Juhan-Vague I; Collen D. On the role of coagulation and fibrinolysis in atherosclerosis. Ann Epidemiol 1992;2:427
43. Apitz-Castro R, Ledezma E, Escalante J, et al. Reversible prevention of platelet activation by (E,Z) -4,5,9-trithiadodeca-1,6,11-triene 9-oxide (ajoene) in dogs under extracorporeal circulation. Arzneimittelforschung 1988;38:901
44. Ali M, Thomson M, Alnaqeeb MA, al-Hassan JM, Khater SH, Gomes SA. Antithrombotic activity of garlic: its inhibition of the synthesis of thromboxane-B2 during infusion of arachidonic acid and collagen in rabbits. Prostaglandins Leukot Essent Fatty Acids 1990;41:95
45. Mayeux PR, Agrawal KC, Tou JS, et al. The effects of allicin, a constituent of garlic oil. Agents Actions 1988;25:182
46. Apitz-Castro R, Badimon JJ, Badimon L. Effect of ajoene, the major antiplatelet compound from garlic, on platelet thrombus formation. Thromb Res 1992;68:145
47. Srivastava KC. Evidence for the mechanism by which garlic inhibits platelet aggregation. Prostaglandins Leukot Med 1986;22:313
48. Apitz-Castro R, Cabrera S, Cruz MR, Ledezma E, Jain MK. Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure. Thromb Res 1983;32:155
49. Bordia A. Effect of garlic on human platelet aggregation in vitro. Atherosclerosis 1978;30:355
50. Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri S. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. Arzneimittelforschung 1993;43:119
51. Kiesewetter H, Jung F, Jung EM, Mroweitz C, Koscielny J, Wenzel E. Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack. Eur J Clin Pharmacol 1993;45:333
52. Harenberg J, Giese C, Zimmermann R. Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia. Atherosclerosis 1988;74:247
53. Chutani SK, Bordia A. The effect of fried versus raw garlic on fibrinolytic activity in man. Atherosclerosis 1981;38:417
54. Gadkari JV, Joshi VD. Effect of ingestion of raw garlic on serum cholesterol level, clotting time and fibrinolytic activity in normal subjects. J Postgrad Med 1991;37:128
55. Lee WM, Lee KT. Lack of effect of phenformin, pyridinolcarbamate combined with a decalcifying agent, and an onion-garlic mixture on growth and necrosis of aortic atherosclerosis in ballooned swine. Exp Mol Pathol 1980;33:345
56. Sarkar AR, De MK. Histopathological studies on the effects of garlic on experimental atherosclerosis. Indian J Pathol Microbiol 1981;24:261
57. Mand JK, Gupta PP, Soni GL, Singh R. Effect of garlic on experimental atherosclerosis in rabbits. Indian Heart J 1985;37:183
58. Mirhadi SA, Singh S, Gupta PP. Effect of garlic supplementation to atherogenic diet on collagen biosynthesis in various tissues of rabbits. Indian Heart J 1990;42:99
59. Orekhov AN, Tertov W, Kudryashov SA, Smirnov VN. Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells. Circ Res 1990;66:311
60. Orekhov AN, Tertov VV, Sobenin IA, Pivovarova EM. Direct anti-atherosclerosis-related effects of garlic. Ann Med 1995;27:63
61. Orekhov AN, Tertov VV. In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells. Lipids 1997 (accepted)
62. Lee ES, Steiner M, Lin R. Thioallyl compounds: potent inhibitors of cell proliferation. Biochim Biophys Acta 1994;1221:73
63. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917
64. Avogaro P, Bittolo Bon G, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988;8:79
65. Orekhov AN, Tertov VV, Mukhin DN, Mikhailenko IA. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells. Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun 1989;162:206
66. Hoff HF, O'Neil J. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler Thromb 1991;11:1209
67. Orekhov AN, Pivovarova EM, Tertov VV. Garlic powder tablets reduce atherogenicity of low density lipoprotein. A placebo-controlled double-blind study. Nutr Metab Cardiovasc Dis 1996;6:21
68. Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993;49:566
69. Horie T, Murayama T, Mishima T, et al. Protection of liver microsomal membranes from lipid peroxidation by garlic extract. Planta Med 1989;55:506
70. Lewin G, Popov I. Antioxidant effects of aqueous garlic extract. 2nd communication: Inhibition of the Cu(2+)-initiated oxidation of low density lipoproteins. Arzneimittelforschung 1994;44:604
71. Popov I, Blumstein A, Lewin G. Antioxidant effects of aqueous garlic extract. 1st communication: Direct detection using the photochemiluminescence. Arzneimittelforschung 1994;44:602
72. Torok B, Belagyi J, Rietz B, Jacob R. Effectiveness of garlic on the radical activity in radical generating systems. Arzneimittelforschung 1994;44:608
73. Kourounakis PN, Rekka EA. Effect on active oxygen species of alliin and Allium sativum (garlic) powder. Res Commun Chem Pathol Pharmacol 1991;74:249
74. Phelps S, Harris WS. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 1993;28:475
75. Simons LA, Balasubramaniam S, Von Konigsmark M, Parfitt A, Simons J, Peters W. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis 1995;113:219
76. Orekhov AN, Tertov W, Sobenin IA, et al. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res 1992;33:805
77. Kiesewetter H. Measurement of plaque regression. Z Phytother 1995;Abstract:18